Navigation Links
Digirad Corporation Sells Northern California Service Hubs
Date:2/2/2009

POWAY, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD), a leading provider of diagnostic imaging products and personnel and equipment leasing services that improve patient care while driving positive healthcare economics, today reported that it has sold the assets related to three northern California service hub locations. The asset purchase agreement with Rancho Santa Fe, Calif.-based MD Office Solutions calls for the sale of portable nuclear imaging cameras, vans and related equipment, and the assignment of certain customer contracts for the former Digirad hub locations in Northern California's Bay Area and Fresno, California. MD Office Solutions is committed to providing outstanding customer care and state of the art imaging equipment manufactured by Digirad.

Digirad CEO Todd Clyde said, "Executing this agreement is an important part of our strategy to focus on a core group of DIS locations, facilitating improved utilization and profitability. We are pleased to have found a partner who has similar business values, specifically those oriented to customer service and employee satisfaction. We look forward to a continued and supportive relationship with MD Office Solutions as they move forward as a business partner."

Michael J. Keenan, the President and Chief Executive Officer of MD Office Solutions, was formerly the President of DIS at Digirad. He commented, "During my tenure at Digirad, I was deeply involved in creating and implementing improved efficiency programs and the DIS centers of influence strategy. I see this as an opportunity to take that experience and to execute, as a partner, a seamless transition and excellent service for the customers that will be served by MD Office Solutions."

About Digirad Corporation

Digirad provides medical diagnostic imaging systems and personnel and equipment leasing services to physicians' offices, hospitals and imaging centers for cardiac, vascular, and general imaging applications. Digirad's Cardius XPO line of nuclear imaging cameras use patented solid-state technology and unique multi (single, dual, triple) head design for superior performance and advanced features for sharper digital images, faster processing, compact size, lighter weight for portability, ability to handle patients up to 500 pounds, and improved patient comfort compared to standard nuclear cameras. Digirad's 2020tc general-purpose nuclear imager has a small footprint and may also be configured for fixed or mobile use to supplement primary imaging. Digirad's installed base of equipment exceeds 600 systems; in addition, a mobile fleet of more than 145 nuclear and ultrasound imaging systems is being used in 21 states, primarily in the eastern, midwestern and southwestern United States. For more information, please visit www.digirad.com. Digirad(R), Digirad Imaging Solutions(R), and Cardius(R) are registered trademarks of Digirad Corporation.

    Investor Contact:                     Company Contact:
    Matt Clawson                          Todd Clyde
    Allen & Caron                         Chief Executive Officer
    949-474-4300                          858-726-1600


'/>"/>
SOURCE Digirad Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Digirad Corporation to Release Third Quarter, Nine-Month Financial Results on October 25, 2007
2. Digirad Corporation Named to Deloitte Technology Fast 50
3. Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results
4. Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement
5. Digirad Corporation Board of Directors Appoints R. King Nelson Chairman
6. Digirad to Introduce New Clinical Standard for Cardiac SPECT
7. Digirad Corporation to Release Fourth Quarter, Year-End Financial Results on February 7, 2008
8. Digirad Corporation Appoints John W. Sayward to Its Board of Directors
9. Digirad Corporation to Release First Quarter Financial Results on April 24, 2008
10. Digirad Corporation Reports Financial Results for First-Quarter 2008
11. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: